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A covalent homodimer probing 
early oligomers along amyloid 
aggregation
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Martino Bolognesi1,4 & Stefano Ricagno1
Early oligomers are crucial in amyloid aggregation; however, due to their transient nature they 
are among the least structurally characterized species. We focused on the amyloidogenic protein 
beta2-microglobulin (β2m) whose early oligomers are still a matter of debate. An intermolecular 
interaction between D strands of facing β2m molecules was repeatedly observed, suggesting that 
such interface may be relevant for β2m dimerization. In this study, by mutating Ser33 to Cys, and 
assembling the disulphide-stabilized β2m homodimer (DimC33), such DD strand interface was locked. 
Although the isolated DimC33 display a stability similar to wt β2m under native conditions, it shows 
enhanced amyloid aggregation propensity. Three distinct crystal structures of DimC33 suggest that 
dimerization through the DD interface is instrumental for enhancing DimC33 aggregation propensity. 
Furthermore, the crystal structure of DimC33 in complex with the amyloid-specific dye Thioflavin-T 
pinpoints a second interface, which likely participates in the first steps of β2m aggregation. The 
present data provide new insight into β2m early steps of amyloid aggregation.
Amyloidogenesis is a complex and non-homogeneous process whereby, during the nucleation phase, 
monomeric protein molecules start to associate, firstly yielding oligomeric species that eventually lead 
to mature amyloid fibrils1. The mechanism of amyloid toxicity is still debated, although several exper-
imental evidences suggest that pre-fibrillar oligomeric species might play a crucial role in determin-
ing cytotoxicity and tissue sufferance2. Shedding light on the molecular bases of oligomer assembly is 
therefore relevant to understand the specific properties of the cytotoxic species. Nevertheless, since the 
oligomers are transient species in equilibrium with higher/lower molecular weight aggregates, only in few 
cases they have been successfully isolated3. Even when isolated in vitro, typically the oligomers are too 
heterogeneous and unstable for high-resolution structural investigations. Accordingly, an experimental 
description of oligomers at the molecular level is generally lacking, most evidences on oligomer structure 
being obtained though spectroscopic techniques or microscopy investigations4. To date computational 
approaches, such as molecular dynamics simulations, are producing increasingly reliable models of pro-
tein oligomerisation5,6.
In order to elucidate the structural bases of oligomer formation we focused on the amyloidogenic 
protein beta-2 microglobulin (β 2m), whose native fold is structurally well characterized, and amyloid 
formation in vitro has been thoroughly described7. β 2m is a 99-residue globular protein with a typical 
immunoglobulin-like fold, composed of seven β -strands arranged in two β -sheets, named ABDE and 
CFG, respectively, according to standard nomenclature of the composing β -strands (Fig.  1a); the two 
sheets are internally linked by a disulphide bond8. β 2m is an aggregation-prone protein responsible 
for two types of amyloid-related diseases: the wild type (wt) protein is responsible for Dialysis-Related 
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Amyloidosis (DRA)9, while a severe hereditary systemic amyloidosis is linked to the pathological β 2m 
D76N mutant10. Physiologically, β 2m is degraded in the kidneys; DRA patients typically suffer from 
kidney dysfunction that results in β 2m accumulation in the serum following dialysis. Over the years, 
β 2m aggregates in the skeletal joints, bones and muscles, resulting in bone fragility and movement 
impairment11.
Wt β 2m aggregation propensity has been extensively studied in the last decades, although one impor-
tant limitation for the study of β 2m aggregation is that the wt protein in vitro is stable for months under 
native conditions. Accordingly, all wt β 2m aggregation protocols are based on conditions under which 
the protein is completely or partially unfolded (low pH, denaturants such 2,2,2-trifluoroethanol (TFE), 
or sodium dodecylsulphate) and the addition of amyloid-fibril seeds to the reaction mixture is neces-
sary12. Thus, such in vitro protocols may not describe the natural β 2m oligomerisation occurring in vivo, 
where the protein is unlikely to be largely unfolded before amyloid deposition takes place. Moreover, the 
Figure 1. Crystal structure of DimC33 and DD strand interface. (A) Ribbon model of one of the two 
chains in DimC33 (blue) superposed on the structure of wt β 2m (green). β -strands are labeled according to 
the standard β 2m nomenclature, Ser33/Cys33 are shown in sticks. (B) A zoomed view into the DD interface 
of four superposed crystal structures of DimC33_ThT (green, pdb code: 4RA3), hexameric structure of 
H13F β 2m (magenta, pdb code: 3CIQ), DimC50 (cyan, pdb code: 3TM6) and DimC20 (yellow, pdb code: 
3TLR), showing the main residues involved in the DD interface as sticks model. (C) Superposition of three 
β 2m non-covalently assembled dimers built through the DD strand interface with DimC33: DimC33_ThT 
in green, hexameric structure of H13F β 2m in magenta, DimC50 structure in cyan, and DimC20 structure 
in yellow. (D) Stereo view of the DD strand interface built by the facing β 2m molecules as observed in the 
structure of DimC33_high. The main residues involved in the interface are shown as sticks.
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addition of seeds allows to study fibril growth, but it fully abolishes the key early process of oligomer 
formation.
Several independent reports suggest that the first oligomeric species formed during β 2m aggregation 
is an elongated dimer: extended oligomers have been observed by mass-spectrometry, and an elongated 
dimer was proposed to be the starting species in β 2m oligomerisation13–16. Among several studies aimed 
at uncovering the structure of β 2m oligomers17,18, Miranker and coworkers reported the crystal structure 
of a hexameric form of the H13F β 2m mutant17, formed under aggregating conditions; such hexameric 
assembly is however not amyloidogenic17.
We recently tested a different approach to the study of β 2m oligomer formation. Single Cys mutations 
were inserted in different β 2m surface regions, and disulphide-linked covalent homodimers were pre-
pared19. The rationale was that a covalent bond between two β 2m molecules acts as a constraint for the 
architecture of the dimer, which can be aggregation permissive or non-permissive. The crystal structures 
of two of such dimers showed a common antiparallel interface between covalent dimers (named the DD 
strand interface): these dimers also proved to be amyloidogenic and assembled as dimer of dimers in 
solution. Notably the S-S bond location in a third engineered homodimer hampers the formation of the 
DD strand interface resulting in a non-amyloidogenic, purely dimeric species in solution. Based on such 
observations, the DD strand interface was proposed as a key association interface involved in the early 
stages of β 2m association under native and non-native conditions19.
The DD strand interface involves the apical region of two β 2m molecules. The D-strands belonging to 
the facing molecules are antiparallel and the two β 2m molecules involved display the same conformation 
and are well superposable. Within each β 2m monomer the DD strand interface involves the D-strand, 
the DE and BC loops, namely regions that have been reported as major players in β 2m amyloid aggrega-
tion19 (Fig. 1). Such intermolecular association interface had also been noted in the hexameric structure 
of the H13F β 2m mutant17.
Following our previous approach, in the present study we engineered a β 2m homodimer where the 
DD strand interface is specifically locked by a disulphide bond (linking the engineered C33 residues of 
two β 2m molecules – DimC33). We speculated that analysis of such a covalently stabilized dimer should 
allow us to assess more directly the role played by association through the DD strand interface in β 2m 
oligomerisation and amyloid formation. DimC33 has been characterized in solution and under aggre-
gation conditions; moreover, we determined three different crystal structures of the covalent dimer, one 
of which hosts the DimC33 complex with Thioflavin (ThT), the hallmark fluorescent dye for amyloid 
aggregates. The data here reported show that a covalently stabilized DD strand interface facilitates β 2m 
aggregation under denaturating and non-denaturating conditions,, suggesting that DimC33 may be used 
as a model system to study β 2m early oligomerisation steps in vitro. Our results recapitulate previous 
data indicating the DD strand interface as the first and favourite intermolecular contact region between 
β 2m molecules under native or aggregating conditions. Furthermore, analysis of the crystal structure of 
DimC33 in complex with ThT strongly points to a second β 2m association interface that may be involved 
in amyloid aggregation.
Results
Recombinant S33C variant β2m homodimers. In order to engineer a β 2m covalent dimer display-
ing a locked DD strand interface, a detailed analysis of the crystal structures displaying such intermolec-
ular association interface (pdb codes: 3TM6, 3TLR, 3CIQ) was performed, and the mutation of Ser33 to 
Cys was chosen based on the following rationale. Firstly, two Ser33 residues belonging to two facing β 2m 
molecules (in the examined crystal structures) fall at a suitable distance to be mutated to Cys and yield a 
disulphide bridge without disrupting or altering the DD interface. Secondly, among the residues, which 
could satisfy the above conditions, a Ser residue was chosen because it is essentially isosteric with Cys.
The S33C β 2m variant was expressed and purified under denaturating conditions and then refolded, 
according to our standard protocols20. In our previous study on covalent β 2m homodimers, in order to 
promote the formation of covalent disulphide linked homodimers, an oxidation reaction proved nec-
essary. To this purpose, after refolding, the monomeric β 2m variants were incubated at high protein 
concentrations in the presence of H2O219, indicating that random encounters between molecules are not 
sufficient for the formation of disulphide linked dimers. Conversely, in the case of the S33C β 2m variant, 
a covalent dimeric species was abundantly present at the end of the purification, in the absence of further 
oxidation reactions. The spontaneous formation of disulphide bonds greatly depends on proper juxtapo-
sition of the two Cys residues involved21. Therefore, the unprompted dimerization of S33C implies that 
in solution, under native conditions, the DD association interface spontaneously brings together two 
monomeric β 2m molecules, and only once the DD interface is properly assembled, the two facing Cys33 
establish the disulphide bond, which results in the formation of the covalent dimeric species (DimC33).
The stability of DimC33 in solution was assessed by circular dichroism. Thermal unfolding monitored 
by Far-UV indicates that, as for wt β 2m, DimC33 unfolds according to a simple sigmoidal curve and 
displays a Tm value close to that of the wt protein (TmDimC33 60.2 ± 0.3 °C; Tmwt 62.4 ± 0.3 °C) (Fig. 2a). 
Then, Far-UV spectra of DimC33 and of wt β 2m in phosphate buffer, in 10% and 20% TFE were col-
lected, showing that native spectra are well superposable and that both proteins display a native second-
ary structure content in 10% TFE; conversely the β 2m fold is perturbed in 20% TFE (Fig. 2b). Thus, the 
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spectroscopic data suggest that the engineered mutation and the achievement of a covalent dimeric state 
do not alter β 2m thermodynamic stability or its overall fold in DimC33.
Aggregation kinetics of DimC33 and wt ß2m in vitro. We studied DimC33 aggregation propen-
sity in vitro at physiological pH conditions (pH 7.4) in the absence of any pre-fibrillar seeds. In 20% (v/v) 
TFE, DimC33 at a final concentration of 1 mg mL−1 aggregates promptly without a lag phase, reaching 
equilibrium within the first 4 hours, and yielding a high ThT binding signal (Fig.  3a); under the same 
conditions wt β 2m remains soluble and does not aggregate. Interestingly, in 10% (v/v) TFE—where 
DimC33 and wt β 2m display CD spectra indicative of native-like conformations—a 5 mg mL−1 solution 
of DimC33 also aggregated. The AFM analysis of the samples after 1 week aggregation showed that 
DimC33 formed fibrils both in 20% TFE (Fig. 3b, left) and in 10% TFE (Fig. 3b, right). The fibril heights 
measured in the two conditions were similar and were in the range between 2.0 and 5.5 nm.
Figure 2. Thermal stability and Far-UV spectra analysis by circular dichroism. (A) Temperature ramps 
for DimC33 in red and wt β 2m in black monitored at 202 nm, temperature slope 50 °C/h. Signals were 
reported as fractional variation of the total change. The melting temperature (Tm) values for DimC33 and 
wt β 2m are shown in the graph. (B) Far-UV spectra for DimC33 and wt β 2m in a buffer containing 100 mM 
sodium chloride, 50 mM sodium phosphate buffer pH 7.4, recorded under three different conditions: No 
TFE (black curves); in presence of 10% (v/v) TFE (red curves); and in 20% (v/v) TFE (blue curves).
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Doxycycline is a known inhibitor of wt β 2m aggregation22. In order to assess doxycycline inhibitory 
effect on DimC33 aggregation, a DimC33 solution was tested for aggregation in the presence of 100 μ M 
and 400 μ M Doxycycline, in 20% TFE. A 100 μ M final concentration of Doxycycline was sufficient to 
block DimC33 aggregation by approximately 85%, compared with a DimC33_20% TFE control solution, 
whereas 400 μ M Doxycycline completely inhibited DimC33 aggregation (Fig. 3c). No fibrillar aggregates 
were detected by AFM in DimC33 samples incubated for 1 week in the presence of doxycycline (not 
shown). Such results are in keeping with previous data on wt protein reporting an IC50 of 47 μ M for 
doxycycline as aggregation inhibitor22.
Figure 3. DimC33: fibrillogenesis at pH7.4. (A) Kinetics of DimC33 fibril formation in 100 mM 
NaCl, 50 mM Na phosphate buffer (pH 7.4) at 37 °C incubation for two weeks, monitored by measuring 
ThT fluorescence at 0, 4, 48, 96, 144, 216, 312 hours. Four samples were tested: DimC33_20% TFE and 
wtβ 2m_20% TFE (1 mg mL−1 protein in 20% TFE); DimC33_10% TFE and wtβ 2m_10% TFE (5 mg mL−1 
protein in 10% TFE). Values represent the average of three independent experiments and error bars 
represent standard deviation (SD). (B) Tapping mode AFM images (height data) of DimC33 fibrillar 
aggregates obtained in 20% TFE (left) and 10% TFE (right). Scan size 500 nm, Z range: left, 37 nm; right, 
15 nm. (C) DimC33 aggregation analysis monitored by ThT fluorescence after one week of incubation at 
37 °C, using the same aggregation conditions as tested under DimC33_20% TFE in three conditions; 0 μ M 
doxycycline, in the presence of 100 μ M and 400 μ M doxycycline. Values represent the average of three 
independent experiments and error bars represent SD.
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X-ray crystal structures of DimC33. In order to assess fine details of the molecular structure of 
DimC33, two crystal structures of DimC33 were determined to 1.9 Å and 1.4 Å resolution, hereafter 
named DimC33_low and DimC33_high, respectively; additionally a crystal structure of DimC33 in 
complex with ThT was determined to 2.8 Å resolution, and named DimC33_ThT. Data collection and 
refinement statistics for the crystal structures are shown in Table 1.
The three crystal structures display three different space groups and crystal packings. The electron 
density is of excellent quality and all β 2m molecules are completely traceable in all three structures. 
Overall, no major structural effects on the β 2m fold are induced by the S33C mutation, either locally 
or globally, in all DimC33 structures, (Fig. 1b,c). The monomeric components of DimC33 most closely 
match the conformation of wt β 2m as observed in its physiologic class I major histocompatibility com-
plex (Table  2). The only noticeable difference occurs in the DE loop (residues 57–60) that displays a 
slightly modified conformation so that Trp60 participates in stacking interactions with Phe56, of the 
Structure (PDB entry)
DimC33-Low 
(4R9H)
DimC33-High 
(4RAH)
DimC33-ThT 
(4RA3)
Data collection
 Beam line ID23-1 (ESRF) ID23-1 (ESRF) P13 (PETRA III, MX1)
 Space Group P4122 C2221 P3221
 Unit cell constants (Å) a = 68.84 b = 68.84 c = 200.04
a = 32.35 b = 47.70 
c = 119.65
a = 80.0 b = 80.0 
c = 177.7
 Resolution (Å) 65.09–1.90 (2.00–1.90)
29.91–1.40 
(1.42–1.40)
59.23–2.80 
(2.95–2.80)
 Rmergea(%) 10.9 (94.0) 6.5 (49.5) 5.9 (113.9)
 I/sig(I) 12.4 (2.2) 10.9 (1.9) 21.4 (2.0)
 Completeness (%) 99.9 (99.6) 98.7 (86.6) 100.0 (100.0)
 Redundancy 8.9 (8.3) 4.5 (3.4) 9.6 (10.0)
 Unique reflections 38985 (5533) 18491 (787) 16940 (2432)
Refinement
 Rworkb(%) 21.17 16.62 17.07
 Rfreeb(%) 24.73 20.94 20.64
 Rms Bond Length 0.013 0.019 0.009
 Rms Bond Angle 1.402 1.919 1.453
 Number of atoms 3480 1021 3407
 Average B, all atoms (Å2) 42.0 17.0 114.0
 Average B, Thioflavin (Å2) – – 102.8
Ramachandran plot
 Most favored region 375 (98.68%) 86 (100%) 367 (94.83%)
 Allowed region 4 (1.05%) 0 (0%) 20 (5.17%)
 Outliers 1 (0.26%) 0 (0%) 0 (0%)
Table 1. Data collection and refinement statistics for DimC33 Structures. Values in parenthesis are for 
the highest resolution shell. a = ∑ − /∑R merge I I Ihkl hkl hkl hkl hkl where I is the observed intensity and 〈 〉I  
is the average intensity. b = ∑ − /∑R work hkl Fo Fc Fohkl  for all data except 5% which were used for Rfree 
calculation.
DimC20 (3TLR) DimC50 (3TM6)
H13F β2m 
(3CIQ) wt β2m (1JF1)
DimC33-High (Mono) 0.62/99 Cα 0.59/98 Cα 1.05/97 Cα 0.97/98 Cα 
DimC33-High (Dimer) 2.41/182 Cα 2.10/192 Cα 1.11/192 Cα –
Table 2.  The SSM superimposed RMS deviations for DimC33 structures with reference models 
DimC20, DimC50, hexameric H13F β2m and wt β2m (Å/Cα pairs superposed).
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same chain, and with His51 and Tyr66 of the second chain within DimC33; the rotation of Tyr63 side 
chain of about 90 degrees is also observed (see Fig. 1b).
The covalent DD strand interface is structurally well conserved in all three DimC33 structures, where 
it maintains the same contact surface of 560 Å2. The overall dimer organization is conserved (r.m.s.d. 
0.57 Å/195 Cα , 1.17 Å/195 Cα , DimC33_high versus DimC33_ThT and versus DimC33_low, respec-
tively); the main regions involved in the association interface are the BC loop (residues 31–37), the 
D strand (residues 51–57), the DE loop (residues 57–6), Phe62, the E strand (residues 64 and 66), as 
observed in previous structures (Fig.  1b–d). The superposition of DimC33 with previously reported 
β 2m dimers, non-covalently associated through the DD strand interface, shows a very similar overall 
monomer-monomer orientation (Fig.  1c and Table  2) and conserved conformations for the residues 
involved (Fig.  1b–d and Table  2). All such data indicate that the S33C mutation minimally affects the 
β 2m fold, and that the C33 – 33C disulphide covalently locks the DD strand interface with negligible 
structural effects Fig. 1b–d.
The DimC33 ThT complex and the ABDE sheet. DimC33 was also crystallized in the presence of 
5 mM ThT. Intriguingly, the crystallographic analysis showed that five ThT molecules are hosted in the 
crystal asymmetric unit (AU), which contains one DimC33 moiety and two halves of a second one (i.e. 
two additional and independent β 2m chains). As a result of crystal packing, β 2m molecules belonging to 
independent DimC33 units interact via their ABDE β -sheets (Fig. 4a); however, two distinct ABDE inter-
faces can be distinguished. In one of these, four ThT molecules are wedged between the ABDE sheets of 
two facing β 2m molecules (4 ThT site); in the other, only one ThT molecule is sandwiched between two 
facing ABDE sheets (1 ThT site) (Fig. 4a). In either case, binding of the ThT molecules does not induce 
Figure 4. Crystal structures of DimC33_ThT and DimC33_low. (A) Cartoon representation of DimC33 
assembly in the crystal structure of DimC33_ThT. The three DimC33 units are colored in cyan, green and 
magenta. Two ThT binding sites are visible: on the left side the 1 ThT site, on the right the 4 ThT site (the 
ThT molecules are colored in red). (B,C) A zoomed representation into the 1 ThT site (B) and into the 4 ThT 
site (C), showing ThT molecules sandwiched between the ABDE sheets of two adjacent DimC33 moieties, 
2Fo-Fc omit electron density map at 1.5σ is clipped around ThT molecules. (D,E) Ribbon representation 
of the ABDE interface as observed (D) in the DimC33_low structure (pdb code: 4R9H); and (E) in the 
hexameric structure of H13F β 2m (pdb code: 3CIQ).
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any conformational adjustments in the β 2m fold, or in the DimC33 assembly. At the 1 ThT site, the ThT 
molecule is sandwiched between Tyr10 residues from two facing β 2m molecules; moreover, Tyr26 and 
Pro14 from both molecules establish van der Waals interactions with ThT (Fig.  4b). At the 4 ThT site, 
the four ThT molecules are stacked on each other, and in stacking contacts with Tyr10 and Tyr63 of the 
β 2m molecules defining the binding site. Tyr26 from both β 2m molecules also help accommodate the 
ThT hydrophobic rings (Fig. 4c).
In order to house one or four ThT molecules, the β 2m chains, which belong to two distinct DimC33 
units, are differently juxtaposed. In particular, the two β 2m molecules defining the 4 ThT site move about 
20 Å apart compared to the 1 ThT site, to make room for the four ThT molecules. Thus, very limited 
direct interactions connect the two β 2m molecules at the 4 ThT site, whereas more direct protein-protein 
contacts take place at the 1 ThT site. Despite such translational adjustments, the two ThT sites maintain 
very similar structural arrangements. The relative orientation of the two β 2m chains defining the ThT 
sites is comparable, and the protein regions involved in ThT binding are conserved. More specifically, 
Tyr10, Tyr26 and Tyr63, the three central residues in the ABDE interface, cross diagonally the sheet 
and confer substantial surface hydrophobicity (Fig. 4). In particular, at both ThT sites Tyr10 establishes 
direct stacking interactions with ThT molecules, even though the ThT molecules do not share the same 
orientation in the two sites.
It must be noted that wide intermolecular packing contacts through the ABDE sheet are established 
also in the absence of ThT. In the structure of DimC33_low (present work) and in the hexameric H13F 
mutant17, highly hydrophobic association interfaces are built via facing ABDE sheets (surface areas of 805 
and 970 Å2, respectively). Although such two ABDE assemblies are not superposable, the two interfaces 
are structurally similar and residues Tyr10, Tyr26 and Tyr63 are clustered in their hydrophobic cores 
(see Fig. 4d,e).
In summary, in the four ABDE packing interfaces examined (the 1 ThT and 4 ThT sites, and the ABDE 
interfaces in DimC33_low and in hexameric β 2m) the orientations of each β 2m monomeric chain may 
vary, the distances between protein chains are somewhat different, and the packing interactions between 
the ABDE sheets can be direct or mediated through ThT molecules. However, the overall conservation 
of protein-protein interaction surface, the binding of ThT, the size of the surfaces, the structural data 
and the marked hydrophobicity of the residues involved, all point at this sheet as a favored site for β 2m 
association during oligomer formation.
Discussion
Elucidating the structure and the underlying interactions of on-pathway oligomers that lead to amyloid 
aggregation is a crucial and challenging task. A structural characterization of the first steps of oligomer 
formation would be the key for a deeper understanding of the aggregation process, and potentially for 
the design of inhibitors hampering the oligomerisation process, and the related protein cytotoxicity.
We selected β 2m as a model of amyloid aggregation, since the protein has been extensively charac-
terized, and several structural determinants of β 2m amyloidogenicity have been uncovered7. In order to 
shed light on the intermolecular interactions that drive the first steps of aggregation, a disulphide-linked 
β 2m homodimer was designed according to a previously proposed strategy19. The engineered S-S bond 
was positioned in order to juxtapose two β 2m monomers along the DD strand interface, which was 
observed as an intermolecular association region17,19. The mutation Ser33 to Cys is structurally con-
servative, and designed to bring together two β 2m molecules through the DD strand interface, without 
altering its structure. From the in vitro biophysical data, and from the crystallographic analysis here 
reported, all evidences suggest that the mutation and the engineered disulphide bond do not affect β 2m 
properties to a significant extent.
Under native conditions, we and others have shown that a minor population of wt β 2m is oligomeric, 
mainly dimeric14,23. The observation that the disulphide bridge stabilizing DimC33 forms spontaneously 
in solution (in the absence of an added oxidizing agent) is indicative of the spontaneous juxtaposition 
of two facing C33 residues; it thus strongly suggests that the DD interface is the prevalent association 
interface underlying β 2m dimerisation under such conditions.
The aggregation data show that DimC33 is much more amyloidogenic than wt β 2m, even though its 
thermodynamic stability and its 3D structure are virtually identical to those of the wt protein. Using a 
standard β 2m aggregation protocol in 20% TFE, we have shown that DimC33 aggregates abundantly, 
but, opposite to wt β 2m, does not require fibril seeds for aggregation to start, an indication that DimC33 
can spontaneously form the early oligomers required for the onset of fibrillogenesis. Analogously to 
wt β 2m early oligomer formation22, doxycyclin proved to be an inhibitor of DimC33 aggregation. 
However, DimC33 was shown to aggregate also in 10% TFE, a condition under which β 2m is prop-
erly folded (Fig.  2b). The data available to date indicate that the amyloidogenic intermediates display 
a native-like structure13,14,24; on these bases, a β 2m variant, such as DimC33, which aggregates starting 
from non-denaturating conditions may prove to be an insightful system allowing the study in vitro of 
wt β 2m early oligomerisation.
Recent reports indicate that the first wt β 2m oligomer formed on the pathway to fibril association 
should be a head-to-head elongated dimer5,13–15. In particular, Rennella et al. also provided evidence that 
the dimer association interface should involve the BC loop region14, a finding that is in keeping with our 
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previous data and with a recently published report13,19. Thus, the data here reported for DimC33, together 
with previous results, point to the DD strand interface as the firstly established protein-protein associ-
ation interface during β 2m aggregation. The increased aggregation propensity of DimC33 compared to 
wt β 2m, would then be the result of the immediate availability of the first on-pathway amyloidogenic 
oligomer, that is DimC33.
Interestingly, the crystal structure of DimC33 in complex with ThT provides further information 
on the β 2m aggregation path. ThT fluorescence is the most widely accepted spectroscopic method to 
discern cross-β fibrils from amorphous aggregate. The ThT molecules are held to intercalate the cross-β 
structure in the fibrils, resulting into a gain of fluorescence. Only two structures of ThT in complex with 
amyloidogenic proteins have been so far reported, and both concern β 2m25. In one of these structures 
(pdb code: 3 MYZ) the authors suggest that ThT molecules are simply trapped between β 2m molecules 
packed in the crystal lattice, while the second structure (pdb code: 3 MZT) presents technical issues that 
prevent a thorough discussion of ThT-β 2m interactions (See Materials and Methods). In this context, 
the DimC33_ThT structure here reported adds substantially new information on ThT binding mode to 
an amyloidogenic protein.
In the DimC33_ThT complex structure, the ThT molecules are nestled between the ABDE sheets of 
two facing β 2m molecules, in a highly hydrophobic environment. Notably, an extended ABDE interface 
between facing β 2m molecules can also be observed in the absence of ThT in DimC33_low (this work), 
and in the hexameric β 2m structure reported earlier17. The reciprocal orientation of the two facing ABDE 
β -sheets displays a high level of variability, but in all cases ABDE β -sheets face each other and the same 
three aromatic residues (Tyr10, Tyr26 and Tyr63) build the hydrophobic core of the association interface. 
Such variability can be accounted for by the presence of several Tyr residues and by the capability of 
hydrophobic interactions to form under different orientations of the contributing residues. The above 
observations point at the ABDE β -sheet as a second key interface involved in β 2m oligomer formation, 
in keeping with a previous report supporting the role of surface aromatic residues in determining β 2m 
amyloid propensity26. The structural adaptability of the ABDE surfaces may also explain the formation 
of several different dimeric/tetrameric building blocks, recently proposed by the EM reconstruction of 
mature β 2m fibrils16.
In summary, our study presents an engineered β 2m covalent dimer, DimC33, displaying the same 
biophysical properties of wt β 2m in solution, such dimer mimics the first oligomer formed during β 2m 
aggregation. Unlike wt β 2m, DimC33 does not require the addition of seeds to start fibrillogenesis, and 
aggregates under conditions where β 2m retains native secondary structure content. Given that in vivo wt 
β 2m likely aggregates from a native-like folded species, DimC33 could then be considered the first model 
system to study β 2m oligomerisation in vitro, resembling more closely the aggregation steps occurring in 
vivo, compared to the current available aggregation protocols based on denaturing conditions. Therefore 
DimC33 may also be an insightful system to test anti-oligomerisation inhibitors. Finally, the properties 
and the structures of DimC33 recapitulate previous evidences and indicate how oligomerisation may 
proceed during aggregation. The first dimeric oligomer would be built across the DD strand interface; 
at a later stage, the aromatic residues located on the ABDE sheet would contribute to the formation of a 
hydrophobic core for further association through a structurally adjustable ABDE interface.
Materials and Methods
Mutagenesis, expression and purification. The synthetic gene coding for the Ser33 to Cys β 2m 
variant was purchased from Eurofins genomics. The gene of interest was inserted into pET21B expression 
vector and transformed into BL21 (DE3) E. coli strain. The mutated β 2m was expressed and purified as 
previously reported27. At the end of the procedure, an additional purification step was introduced to 
separate the spontaneously formed DimC33 by size-exclusion chromatography (Superdex75 16/60 GE 
healthcare) and eluted with 20 mM Sodium Phosphate buffer pH 7.4.
Circular dichroism. Circular dichroism (CD) studies were carried out on a Jasco J810 spectropola-
rimeter equipped with a Peltier system for temperature control and analyzed by means of Jasco soft-
ware. All measurements were recorded at 0.1 mg/mL protein concentration in 100 mM sodium chloride, 
50 mM sodium phosphate buffer pH 7.4 by using a 0.1 cm path length cuvette. Spectra were recorded in 
plain buffer or in buffer supplied with 10% or 20% TFE at 37 °C. Temperature ramp measurements were 
recorded at 202 nm from 20 to 95 °C (temperature slope 50 °C/h). Tm values were calculated from the 
first derivative of the recorded traces.
Aggregation kinetics. DimC33 aggregation experiments were performed as unseeded reaction by 
incubating samples of 100 μ L at 37 °C for two weeks, without agitation. The following aggregation condi-
tions were tested: DimC33_20% TFE (1 mg mL−1 DimC33 in 20% TFE, 100 mM Sodium chloride, 50 mM 
Sodium phosphate buffer pH 7.4) according to a standard protocol28; DimC33_10% TFE (5 mg mL−1 
DimC33 in 10% TFE, 100 mM Sodium chloride, 50 mM Sodium phosphate buffer pH 7.4). Unseeded 
aggregation experiments on wt β 2m were also performed as controls. Aggregation kinetics were mon-
itored by means of VARIAN Cary Eclipse spectrofluorimeter by measuring ThT fluorescence signal at 
excitation and emission wavelength of 445 and 480 nm, respectively29.
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The inhibitory effect of doxycycline on DimC33 aggregation was studied under the same aggrega-
tion condition as employed for DimC33_20% TFE, by monitoring ThT fluorescence binding signal and 
inspecting sample morphology by AFM after one week of incubation at 37 °C without agitation. Two 
doxycycline concentrations were screened: DimC33_Doxy100 containing 100 μ M Doxycycline; and 
DimC33_Doxy400 containing 400 μ M Doxycycline. DimC33_20% TFE aggregation was used as control 
model. The measurements are the average of three independent experiments. Doxycycline, TFE and ThT 
were purchased from SIGMA-Aldrich.
Atomic force microscopy. For AFM inspection, DimC33 samples were diluted 500-fold. A 10 μ l 
aliquot was deposited on a freshly cleaved mica substrate and dried under mild vacuum. Tapping mode 
AFM images were acquired in air using a Dimension 3100 Scanning Probe Microscope equipped with 
a ‘G’ scanning head (maximum scan size 100 μ m) and driven by a Nanoscope IIIa controller, and a 
Multimode Scanning Probe Microscope equipped with “E” scanning head (maximum scan size 10 μ m), 
driven by a Nanoscope IV controller (Digital Instruments – Bruker). Single beam uncoated silicon 
cantilevers (type OMCL-AC160TS, Olympus) were used. The drive frequency varied between 270 and 
330 kHz, the scan rate was between 0.5 and 0.8 Hz. Aggregate size was measured from the height in cross 
section of topographic AFM images.
Crystallization and structure determination. DimC33 was crystallized under three different con-
ditions by mixing equal amounts of 8 mg mL−1 protein and reservoir solutions containing: (i) DimC33_
low: 25% v/v PEG 4 K, 0.2 M Imidazole-Malate pH7.0; (ii) DimC33_high: 28% PEG 400, 0.2 M Calcium 
chloride dihydrate, and 0.1 M Hepes sodium pH7.5; (iii) DimC33_ThT: 25% PEG 4 K, 0.1 M Sodium 
chloride, 5 mM ThT, and 0.1 M Hepes sodium pH8.0–8.2. All DimC33 crystals were grown at 20 °C, using 
the sitting drop vapor diffusion crystallization method. DimC33_low and DimC33_ThT crystals were 
cryo-protected in 20–33% glycerol solution containing the respective crystallization mother liquor, and 
cryo-cooled in liquid nitrogen. DimC33_low and DimC33_high X-ray diffraction data were collected 
at ID23-1 beam-line (ESRF Grenoble), and DimC33_ThT X-ray diffraction data were collected at P13 
beamline (PETRA Hamburg). DimC33_low X-ray data were processed using MOSFLM30 and SCALA 
from the CCP4 software suite31 and XDS32 for DimC33_high and DimC33_ThT. The 3D structures of 
DimC33 were determined by molecular replacement using the Balbes software suite33. All structures 
were refined using Phenix.refine34 and REFMAC535. A twin fraction of 0.46 was estimated by Xtriage34. 
Therefore an amplitude based twin refinement protocol was applied during DimC33_ThT refinement 
process in REFMAC5. Model building and structural analysis for all DimC33 structures were carried out 
with COOT36 and figures were prepared with Pymol and CCP4MG37,38. Omit-map has been generated 
by Phaser suite34 using the annealing option.
Analysis of 3 MZT Structure. The structure with the PDB code 3 MZT was reported as a hexameric 
H13F β 2m mutant in complex with Thioflavin (ThT)25. The structure was determined at 2.70 Å resolu-
tion. The three ThT molecules modeled in the complex are sandwiched at three intermolecular inter-
faces present in the hexameric assembly; each ThT molecule is presented in two alternative, but almost 
superimposable, conformations each at 0.5 occupancy. Temperature factors for ThT atoms range between 
80 and 120 Å2 for each of the two conformations; neighboring protein residues, all modeled with full 
occupancy, display B-factors mainly in the 45–70 Å2 range.
When the 3 MZT structure was refined (in our lab, using data from the PDB database) in the absence 
of the ThT molecules, the residual ThT electron density for each binding site was reduced to a roughly 
spheroidal blob, much smaller than the size of a ThT molecule. Based on such observations, the 3 MZT 
molecular model of ThT interaction with β 2m was not considered for the structural comparisons here 
reported.
Structure deposition. Structure factors and coordinates have been deposited in the Protein Data Bank 
under accession codes: 4R9H for DimC33_low, 4RAH for DimC33_high and 4RA3 for DimC33_ThT.
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